Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  yttrium Y 90-edotreotide
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Dosimetry-Guided PRRT Using Gallium Ga 68-edotreotide PET and Yttrium Y 90-edotreotide in Treating Patients with Neuroendocrine or Other Somatostatin Receptor Positive Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 6 months to 90 years
Trial IDs: 201412770, NCI-2015-00861, NCT02441088
Start Over